Kyverna Therapeutics Inc
NASDAQ:KYTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
Kyverna Therapeutics Inc
NASDAQ:KYTX
|
US |
|
Alset International Ltd
SGX:40V
|
SG |
|
S
|
Spring Ventures Ltd
TASE:SPRG
|
IL |
|
Prostar Holdings Inc
XTSX:MAPS
|
US |
|
A
|
Arem Pacific Corp
OTC:ARPC
|
AU |
|
U
|
United Airlines Holdings Inc
BMV:UAL
|
US |
|
J
|
JCDecaux SE
XMUN:DCS
|
FR |
|
S
|
Superior Plus Corp
TSX:SPB
|
CA |
|
G
|
GEA Group AG
F:G1A
|
DE |
|
T
|
Tokio Marine Holdings Inc
DUS:MH6
|
JP |
|
B
|
Barclays PLC
XMUN:BCY
|
UK |
|
Urja Global Ltd
NSE:URJA
|
IN |
Shareholder Yield
Current shareholder yield for KYTX is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
KYTX Price
Kyverna Therapeutics Inc
| Average Annual Return | 63.12% |
| Standard Deviation of Annual Returns | 124.77% |
| Max Drawdown | -94% |
| Market Capitalization | 433.5m USD |
| Shares Outstanding | 60 800 000 |
| Percentage of Shares Shorted | 11.76% |
